$ABT Abbott Q3 2026 Earnings
- Adj EPS $1.42, Est. $1.42
- Net Sales $13.01B, Est. $13B
- Comparable Sales +7%
- Sees Q4 Adj EPS $1.62–$1.67
- Reaffirms FY EPS Guidance
- Plans to Separate Global Nutrition Business Into Public Company by End-2027
- Daniel Salvadori to Become CEO of New Nutrition Company
- Separation Through Tax-Free Distribution to Shareholders
- Separation Won't Impact 2026 or 2027 Guidance
- Expects One-Time Charges Related to Transaction